Follow
James Heward
James Heward
Bates Cancer Institute
Verified email at qmul.ac.uk
Title
Cited by
Cited by
Year
Long non-coding RNAs in the regulation of the immune response
JA Heward, MA Lindsay
Trends in immunology 35 (9), 408-419, 2014
4182014
Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes
NE Ilott, JA Heward, B Roux, E Tsitsiou, PS Fenwick, L Lenzi, I Goodhead, ...
Nature communications 5 (1), 3979, 2014
340*2014
Long intergenic noncoding RNAs mediate the human chondrocyte inflammatory response and are differentially expressed in osteoarthritis cartilage
MJ Pearson, AM Philp, JA Heward, BT Roux, DA Walsh, ET Davis, ...
Arthritis & rheumatology 68 (4), 845-856, 2016
1302016
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
S Araf, J Wang, K Korfi, C Pangault, E Kotsiou, A Rio-Machin, T Rahim, ...
Leukemia 32 (5), 1261-1265, 2018
1282018
Reduced expression of histone methyltransferases KMT2C and KMT2D correlates with improved outcome in pancreatic ductal adenocarcinoma
JBN Dawkins, J Wang, E Maniati, JA Heward, L Koniali, HM Kocher, ...
Cancer research 76 (16), 4861-4871, 2016
962016
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
AF Al Seraihi, A Rio-Machin, K Tawana, C Bödör, J Wang, A Nagano, ...
Leukemia 32 (11), 2502-2507, 2018
692018
Catalog of differentially expressed long non-coding RNA following activation of human and mouse innate immune response
BT Roux, JA Heward, LE Donnelly, SW Jones, MA Lindsay
Frontiers in immunology 8, 1038, 2017
632017
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis
PD Hamann, BT Roux, JA Heward, S Love, NJ McHugh, SW Jones, ...
Scientific Reports 7 (1), 8024, 2017
432017
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
JA Heward, L Konali, A D’Avola, K Close, A Yeomans, M Philpott, ...
Blood, 2021
422021
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations
K Korfi, S Ali, JA Heward, J Fitzgibbon
Epigenetics 12 (5), 370-377, 2017
402017
Epigenetic dysregulation in follicular lymphoma
S Araf, J Okosun, L Koniali, J Fitzgibbon, J Heward
Epigenomics 8 (1), 77-84, 2016
292016
Knockdown of nuclear-located enhancer RNAs and long ncRNAs using locked nucleic acid GapmeRs
BT Roux, MA Lindsay, JA Heward
Enhancer RNAs: Methods and Protocols, 11-18, 2017
242017
Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells
JA Heward, BT Roux, MA Lindsay
FEBS letters 589 (3), 396-406, 2015
202015
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1
AS Coetzee, EP Carter, L Rodríguez-Fernández, J Heward, Q Wang, ...
Oncogene 42 (7), 491-500, 2023
152023
Precision medicine and lymphoma
JA Heward, EA Kumar, K Korfi, J Okosun, J Fitzgibbon
Current opinion in hematology 25 (4), 329-334, 2018
102018
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction
NS Clayton, EP Carter, AE Fearon, JA Heward, L Rodríguez Fernández, ...
International Journal of Molecular Sciences 24 (7), 6228, 2023
22023
Non-coding mutations at enhancer clusters contribute to pancreatic ductal adenocarcinoma
MB Patel, E Maniati, SS Atanur, D Pal, A Rio-Machin, J Heward, ...
bioRxiv, 2023.06. 28.546873, 2023
12023
S844 KDM5 inhibition offers a novel therapeutic strategy for the treatment of kmt2d mutant lymphomas
J Heward, L Koniali, A D’Avola, K Close, A Yeomans, P Johnson, ...
HemaSphere 3 (S1), 376-377, 2019
12019
Targeting FGFR signaling to disrupt cellular cross-talk in pancreatic cancer
A Coetzee, E Carter, J Heward, F Mardakheh, R Grose, H Kocher
12019
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
S Araf, J Wang, K Korfi, C Pangault, E Kotsiou, A Rio-Machin, T Rahim, ...
Leukemia 33 (6), 1540, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20